Skip to main content
SpringerLink
Log in

Leber und Pankreas

  • Chapter
Therapie der Krankheiten des Kindesalters

  • 45 Accesses

Zusammenfassung

Die Leber ist das zentrale Stoffwechselorgan des Organismus. Ihre Funktion besteht in zahlreichen Stoffwechselreaktionen, durch die die aus dem Darm über die Pfortader zugeführten Zucker und Aminosäuren und die vorwiegend auf dem Umweg über den Ductus thoracicus zuströmenden Fette umgesetzt werden. Das beim Erythrozytenabbau in der Milz und dem übrigen RES freigesetzte Bilirubin wird über die Galle ausgeschieden. Zahlreiche endogene und exogene Substanzen werden durch Koppelung an Glukuronsäure, Sulfat oder Glykokoll „entgiftet“, d.h. wasserlöslich und harnfähig gemacht. Aus Aminogruppen bzw. Ammoniak wird Harnstoff gebildet. Die meisten Gerinnungsfaktoren werden in der Leber synthetisiert.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  1. Consensus Conference (1981) Diagnosis and treatment of Reye’s syndrome. JAMA 246: 2441–2444.

    Article  Google Scholar 

  2. Feist D 81986) Wiederzulassung zu Gemeinschaftseinrichtungen für Kinder nach einer Hepatitis B. Pä-diatPrax 33:333-335.

    Google Scholar 

  3. Gerken G, Meyer zum Büschenfelde KH (1991) Virale Hepatitiden. Dtsch Ärztebl 88: B–792–797.

    Google Scholar 

  4. Gladtke E, Schauseil-Zipf U (1987) Reye-Syndrom. Monatsschr Kinderheilkd 135: 699–704.

    PubMed  CAS  Google Scholar 

  5. Hess G (1991) Interferon bei chronischen Virushepatitiden. Dtsch Ärztebl 88: B–786–791.

    Google Scholar 

  6. Lam KC, Lai L, Trepo C, Wu PC (1981) Deleterious effect of prednisolone in HbsAg-positive chronic active hepatitis. N Engl J Med 304: 380–386.

    Article  PubMed  CAS  Google Scholar 

  7. Maggiore G, Bernard O, Hadchouel M, Hadchouel P, Odiévre M, Alagille D (1984) Treatment of autoimmune chronic active hepatitis in childhood. J Pediat 104: 839–844.

    Article  PubMed  CAS  Google Scholar 

  8. Maier KP (1991) Hepatitis — Hepatitisfolgen, 3. Aufl. Thieme, Stuttgart.

    Google Scholar 

  9. Mowat AP (1987) Liver disorders in childhood, 2nd edn. Butterworths, London.

    Google Scholar 

  10. Paumgartner G, Strohmeyer G (Hrsg) (1991) Chronische Virushepatitis und ihre Behandlung mit Interferon alfa. Springer, Berlin Heidelberg New York.

    Google Scholar 

  11. Perrillo RP, Schiff ER, Davis GL et al. (1990) A randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323: 295–301.

    Article  PubMed  CAS  Google Scholar 

  12. Silverberg M, Wherett B, Worden E, Neumann PZ (1969) An evaluation of rest and low fat diets in the management of acute infectious hepatitis. J Pediat 74: 260–264.

    Article  PubMed  CAS  Google Scholar 

  13. Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH (1975) Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 16: 876–883.

    Article  PubMed  CAS  Google Scholar 

  14. Williams C, Weber T, Cullen J, Kane M (1983) Hepatitis B transmission in school contacts of retarded HBsAg carrier students. J Pediat 103: 192–196.

    Article  PubMed  CAS  Google Scholar 

  15. Zakim D, Boyer TD (1990) Hepatology. Saunders, Philadelphia.

    Google Scholar 

  16. Balistreri WF (1985) Neonatal cholestasis. J Pediat 106: 171–184.

    Article  PubMed  CAS  Google Scholar 

  17. Cohen MI, Gartner LM (1972) The use of medium chain triglycerides in the management of biliary atresia. J Pediat 79: 379–384.

    Article  Google Scholar 

  18. Garnter JC, Zitelli BJ, Malatack JJ, Shaw BW, Iwatsuki S, Starzl TE (1984) Orthotopic liver transplantation in children: two-year experience with 47 patients. Pediatrics 74: 140–145.

    Google Scholar 

  19. Lally KP, Kanegaye J, Matsumura M, Rosenthal P, Sinatra F, Atkinson JB (1989) Perioperative factors affecting the outcome following repair of biliary atresia. Pediatrics 83: 723–726.

    PubMed  CAS  Google Scholar 

  20. Leuschner U (1984) Medikamentöse Auflösung von Gallensteinen. Arzneimitteltherapie 2: 143–152.

    Google Scholar 

  21. Rambow A, Staritz M, Klose P, Thelen M, Meyer zum Büschenfelde KH (1989) Extrakorporale Stoßwellenlithotripsie von Gallenblasensteinen: Wieviele Patienten sind geeignet? Dtsch Med Wochenschr 114: 895–898.

    Article  PubMed  CAS  Google Scholar 

  22. Schweizer P, Müller G (1984) Gallengangsatresie. Cholestase-Syndrome im Neugeborenen-und Säuglingsalter. Hippokrates, Stuttgart.

    Google Scholar 

  23. Stiehl A, Thaler MM, Admirand WH (1972) The effect of phenobarbital on bile salts and bilirubin in patients with intrahepatic and extrahepatic cholestasis. N Engl J Med 286: 858–861.

    Article  PubMed  CAS  Google Scholar 

  24. Takiff H, Fonkalsrund EW (1984) Gallbladder disease in childhood. Am J Dis Child 138: 565–568.

    PubMed  CAS  Google Scholar 

  25. Alvarez F, Bernhard O, Brunelle F, Hadchouel P, Odièvre M, Alagille D (1983) Portai obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediat 103: 696–702.

    Article  PubMed  CAS  Google Scholar 

  26. Alvarez F, Bernhard O, Brunelle F, Hadchouel P. Odièvre M, Alagille D (1983) Portai obstruction in. children. II. Results of surgical portosystemic shunts. J Pediat 103: 703–707.

    Article  PubMed  CAS  Google Scholar 

  27. Bolkenius M (1981) Portale Hypertension im Kindesalter. Hippokrates, Stuttgart.

    Google Scholar 

  28. Fonkalsrud EW (1982) Long-term results following surgical management of portal hypertension in children. Z Kinderchir 35: 57–61.

    PubMed  CAS  Google Scholar 

  29. Maier KP (1986) Die medikamentöse Behandlung der Ösophagusvarizenblutung. Dtsch Med Wochenschr 111: 306–313.

    Article  PubMed  CAS  Google Scholar 

  30. Rössle M, Haag K, Noeldge G et al. (1990) Hämodynamische Konsequenzen der portalen Dekompression: Welches ist der optimale Shunt? Z. Gastroenterol 28: 630–634.

    PubMed  Google Scholar 

  31. Rössle M, Richter GM, Noeldge G et al. (1989) Der intrahepatische portosystemische Shunt. Dtsch Med Wochenschr 114: 1511–1516.

    Article  PubMed  Google Scholar 

  32. Paquet KJ, Kalk JF, Koussouris P (1986) Sofortsklerosierung der akuten Ösophagusvarizenblutung während der Notfallendoskopie. Dtsch Med Wochenschr 111: 668–671.

    Article  PubMed  CAS  Google Scholar 

  33. Abman S, Ogle J, Butler-Simon N, Rumack C, Accurso F (1988) Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediat 113: 826–830.

    Article  PubMed  CAS  Google Scholar 

  34. App EM, King M, Helfsrieder R, Köhler D, Matthy H (1990) Acute and long-term amiloride inhalation in cystic fibrosis lung disease. Am Rev Respir Dis 141: 605–612.

    Article  PubMed  CAS  Google Scholar 

  35. Buchdahl RM, Fulleylove C, Marchant JL, Warner JO, Brueron MJ (1989) Energy and nutrient intakes in cystic fibrosis. Arch Dis Child 64: 373–378.

    Article  PubMed  CAS  Google Scholar 

  36. Durie P, Pencharz PB (1989) A rational approach to the nutritional care of patients with cystic fibrosis. JR Soc Med 62(Suppl 16): 11–16.

    Google Scholar 

  37. Feldman CL, Lewiston N, Fernbach SD, O’Brien WEO, Williamson R, Wainwright BJ, Beaudet AL (1989) Prenatal diagnosis of cystic fibrosis by using linked DNA markers in 138 pregnancies at 1-in-4 risk. Am J Med Genet 32: 328.

    Google Scholar 

  38. Goodchild C, John A, Dodge JA (1985) Cystic fibrosis. Manual of diagnosis and management, 2nd edn. Baillière Tindall, London.

    Google Scholar 

  39. Hoiby N (1984) The management of pseudomonas chest infections — the way forward, cystic fibrosis: horizons. Wiley, Chichester New york, pp 87–97.

    Google Scholar 

  40. Hubbard RC, McElvaney NG, Birrer P et al (1992) A preliminary study of aerolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med 326: 812–815.

    Article  PubMed  CAS  Google Scholar 

  41. Hudson VL, Wielinski CL, Regelmann WE (1993) Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before age of two years. J Pediatr 122: 854–860.

    Article  PubMed  CAS  Google Scholar 

  42. Kearns GL, Pharm D, Trang JM (1986) Introduction to pharmacokinetics: aminoglycosides in cystic fibrosis as a prototype. J Pediatr 108: 847–853.

    Article  PubMed  CAS  Google Scholar 

  43. Kerem BS, Rommens JM, Buchmann JA et al (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073–1080.

    Article  PubMed  CAS  Google Scholar 

  44. Knowles MR, Church NL, Waltner WE, Yankaskas JR, Gilligan P, King M, Edward LJ, Helms RW, Boucher RC (1990) A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med 322: 1189–1194.

    Article  PubMed  CAS  Google Scholar 

  45. Littlewood JM, Smye SW, Cunliffe H (1993) Aerosol antibiotic treatment in cystic fibrosis. Arch Dis Child 68: 788–792.

    Article  PubMed  CAS  Google Scholar 

  46. McElvaney NG, Hubbard RC, Birrer P, Chernick MS, Caplan DB, Frank MM, Crystal RG (1991) Aerosol alpha-1-antitrypsin treatment for cystic fibrosis. Lancet 337: 392–394.

    Article  PubMed  CAS  Google Scholar 

  47. Moss RB (1990) Cystic fibrosis. Infection, immunopathology and host response. Humana, Clifton NJ.

    Google Scholar 

  48. Park RW, Grand RJ (1981) Gastrointestinal manifestations of cystic fibrosis: a review. Gastroenterology 81: 1143.

    PubMed  CAS  Google Scholar 

  49. Riordan JR, Rommens JM, Kerem BS et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066–1073.

    Article  PubMed  CAS  Google Scholar 

  50. Shak S, Capon DJ, Helmiss R, Marsters SA, Baker CL (1990) Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 23: 9188–9192.

    Article  Google Scholar 

  51. Taussig LM (1984) Cystic fibrosis. Thieme-Stratton, New York.

    Google Scholar 

  52. Tizzano EF, Buchwald M (1992) Cystic fibrosis: beyond the gene to therapy. J Pediatr 120: 337–349.

    Article  PubMed  CAS  Google Scholar 

  53. Tizzano EF, Buchwald M (1993) Recent advances in cystic fibrosis research. J Pediatr 122: 985–988.

    Article  PubMed  CAS  Google Scholar 

  54. Whitehead B, Helms P, Goodwin M, Martin T, Task B, Serrano E, Scott JP, Smyth RL, Higenbottam TW, Wallwork J, Elliott M, de Levai M (1991) Heartlung transplantation for cystic fibrosis. 1: Assessment. Arch Dis Child 66: 1018–1021.

    Article  PubMed  CAS  Google Scholar 

  55. Wood A, Higenbottam T, Jackson M, Scott J, Steward S, Wallwork J (1989) Airway mucosal microelectric potential difference in cystic fibrosis after lung transplantation. Am Rev Respir Dis 140: 1645–1649.

    Article  PubMed  CAS  Google Scholar 

  56. Arnold R (1986) Endokrine gastrointestinale Tumoren. In: Gugler R, Holtermüller H (Hrsg) Therapie gastrointestinaler Erkrankungen. Thieme, Stuttgart, S 300–311.

    Google Scholar 

  57. Crombleholme TM, der Lorimier AA, Way LW et al (1990) The modified Puestow procedure for chronic relapsing pancreatitis in children. J Pediat Surg 25: 749–754.

    Article  PubMed  CAS  Google Scholar 

  58. Hadorn HB (1987) The exocrine pancreas. In: Anderson CM, Burke V, Gracey M (eds) Pédiatric gastroenterology, 2nd edn. Blackwell, London, pp 456–502.

    Google Scholar 

  59. Kopelman H, Forstner G, Durie PR, Hamilton JR et al (eds) Pediatric gastrointestinal disease. Decker, Philadelphia Toronto, pp 1171–1244.

    Google Scholar 

  60. Layer P, Singer MV, Goebell H (1989) Akute Pankreatitis. Fortschr Med 107: 119–123 und 139-143.

    PubMed  CAS  Google Scholar 

  61. Weizmann Z, Durie PR (1988) Acute pancreatitis in childhood. J Pediat 113: 24–29.

    Article  Google Scholar 

Download references

Authors
  1. H. Wehinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Stephan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. G. Wiesemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Götze
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kinderpoliklinik, Ludwig-Maximilians-Universität, Pettenkoferstraße 8a, D-80336, München, Deutschland

    Dietrich Reinhardt (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wehinger, H., Stephan, U., Wiesemann, H.G., Götze, H. (1994). Leber und Pankreas. In: Reinhardt, D. (eds) Therapie der Krankheiten des Kindesalters. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-22535-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-22535-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-22536-3

  • Online ISBN: 978-3-662-22535-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation